Eminence Capital, LP Tandem Diabetes Care Inc Transaction History

Eminence Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $29.3 Million - $63.7 Million	2,052,892 Added 65.85%	5,170,451 $153 Million
Q2 2023 Aug 14, 2023	BUY	$24.18 - $42.46 $15.7 Million - $27.5 Million	647,902 Added 26.23%	3,117,559 $76.5 Million
Q1 2023 May 15, 2023	SELL	$35.86 - $46.5 $11.3 Million - $14.6 Million	-313,816 Reduced 11.27%	2,469,657 $100 Million
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $42.3 Million - $67 Million	1,192,686 Added 74.97%	2,783,473 $125 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $69.6 Million - $110 Million	1,590,787 New	1,590,787 $76.1 Million

352

73M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.38B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.